OPPENHEIMER EUROPE LTD.

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +6.4%

  £22,901,248 → £24,358,974

• Cash

  +29.2%

  £6,222,621 → £8,037,677

• Net assets

  —

  Not reported

• Employees

  +5.4%

  74 → 78

• Operating profit

  -99%

  -£2,752,486 → -£5,478,059

• Profit before tax

  -66.2%

  -£3,706,362 → -£6,158,331

• Wages

  +17.9%

  £15,061,673 → £17,754,354

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. OPPENHEIMER EUROPE LTD. 2011-06-28 → present
2. OPPENHEIMER EU LTD 2008-05-16 → 2011-06-28

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“To date the Company has not identified any events or conditions that raise substantial doubt about Oppenheimer Europe Ltd 's ability to continue as a going concern for at least one year from the date the financial statements are to be issued.”

Group structure

1. OPPENHEIMER EUROPE LTD. · parent
   1. Oppenheimer Services, Unipessoal Lda. · Portugal · Fund Placement & Advisory ("FPA") business

Significant events

• “The Company has continued to invest in the IBK business in line with the global strategy of the firm and added a Capital Markets Group consisting of two Managing Directors, one Director and one Associate during 2024, as well as one Healthcare Managing Director in May 2024 in order to further expand our sector expertise within our European Corporate Finance division.”
• “The Company received five capital injections from the Parent Company in 2024 for a total of $12m ($3m in March 2024 and May 2024, and $2m in August 2024, October 2024 and November 2024) in order to meet its capital requirements throughout the year.”
• “As part of the Company's commitment to reduce its carbon footprint, the company moved into a new sustainable building in December 2022 which has enabled us to have a more efficient office and be able to further reduce our Carbon footprint in the future.”
• “The company achieved a Carbon Neutral verification from the Carbon Trust, valid until 30 May 2025 for the year 2022. This verification enabled Oppenheimer to demonstrate its commitment to decarbonisation, verified against PAS 2060, the internationally recognised standard for Carbon Neutrality, and played an important role in identifying key actions.”
• “In 2022 the Company undertook an ad hoc risk assessment in response to the Russian invasion of Ukraine. The Company's position has not changed and considers its exposure to the war as low.”
• “The Company is continuing to build scale in its three businesses. The Board of Directors is committed to recruit senior investment bankers and expand coverage within the core global industry verticals, in line with the group investment banking strategy.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.